Merck to acquire Verona Pharma for $10 billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Morgan Stanley Reiterates Equalweight Rating on Merck (MRK)
July 10, 2025 7:43 AM EDTMorgan Stanley analyst Terrance Flynn reiterated an Equalweight rating and $99.00 price target on Merck (NYSE: MRK).
The analyst comments "Financials: The transaction is expected to close in 4Q25 and will result in the capitalization of most of the purchase price as an... More
